Cooley advised Radionetics Oncology on the transaction, and Wilson Sonsini Goodrich & Rosati acted as patent counsel for Radionetics Oncology and advised the company on patent....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati acted as Dida’s U.S. and Hong Kong counsel in the IPO and SEHK listing. China ride-sharing app operator Dida Inc. (Dida)...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Hyperplane on the transaction. Brazil-based Nubank (NU) announced it has agreed to acquire Hyperplane, a data intelligence company from Silicon...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Entrata in the transaction, and Goldfarb Gross Seligman represented Colleen AI. Entrata®, a leading AI-enabled multifamily Operating System (OS), announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati acted as the U.S. and Hong Kong counsel to Ascentage Pharma in the transaction. Ascentage Pharma Group International (Ascentage Pharma) (6855.HK)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised SewerAI on the transaction. SewerAI, a global leader in AI and cloud-driven sewer condition assessment, announced the completion of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised a16z on the transaction. Talkiatry, a leading provider of high-quality, in-network psychiatric care, announced the completion of a $130 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Mobile Health on the transaction, while Paul Hastings and Bass, Berry & Sims advised H.I.G. Growth Partners. H.I.G. Growth Partners...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Iambic Therapeutics on the transaction. Iambic Therapeutics (Iambic), a clinical-stage biotechnology company, announced the closing of an oversubscribed $50 million...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Avidity Biosciences, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction. Cooley...
You must be a Standard 1 Year member to access this content.
